Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Withania somnifera in Amyotrophic Lateral Sclerosis
NCT05031351Phase 2Unknown
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Oct 2021
- Primary completion
- Jul 2022
- Countries
- 1
01
Overview
A Phase 2 trial of withania somnifera in amyotrophic lateral sclerosis (ALS), sponsored by Sunnybrook Health Sciences Centre. Status: unknown.
02
Drugs
withania somnifera
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT05031351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05031351.